LexaGene Blog Diagnostics Diary

Shortcomings in traditional culture testing leave the cannabis industry in search of methods that can enumerate or count the presence of microbes whether dead or alive.

LexaGene's CEO Jack Regan was featured in a roundtable for Frontline Genomics Magazine on infectious disease control.
1 2 3 4